GW Pharmaceuticals EBITDA margin
What is the EBITDA margin of GW Pharmaceuticals?
The EBITDA margin of GW Pharmaceuticals is -9.24%
What is the definition of EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin of companies in the Health Care sector on NASDAQ compared to GW Pharmaceuticals
Companies with ebitda margin similar to GW Pharmaceuticals
- TransMedics has EBITDA margin of -9.29%
- Vinco has EBITDA margin of -9.28%
- Netlist has EBITDA margin of -9.26%
- Besunyen has EBITDA margin of -9.26%
- Diagnostic Medical Systems S.A has EBITDA margin of -9.25%
- Roblox has EBITDA margin of -9.25%
- GW Pharmaceuticals has EBITDA margin of -9.24%
- SML Isuzu has EBITDA margin of -9.22%
- Nanoxplore Inc has EBITDA margin of -9.22%
- Hong Kong Food Investment has EBITDA margin of -9.22%
- UFO Moviez India has EBITDA margin of -9.21%
- Uniphos Enterprises has EBITDA margin of -9.19%
- China Technology Solar Power has EBITDA margin of -9.18%